DSLT in Normal Tension Glaucoma (NTG) Asian Eyes
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorNgoc Nguyen Inc.
About this trial
The goal of this clinical trial is to evaluate the efficacy of direct selective laser trabeculoplasty (DSLT) or laser treatment in Asian patients with normal tension glaucoma. The main question it aims to answer is:
Does the DSLT reduce intraocular pressure (IOP) and medication use in Asian NTG subjects? Participants will attend routine follow-up visits with their eye surgeon and glaucoma testing such as optical coherence tomography (OCT) imaging and visual field test(s) after the laser study treatment.
Eligibility criteria
Qualifiers
Asian descent
NTG diagnosis: glaucomatous optic neuropathy in patients with IOP measurements consistently lower than 21 mmHg
Mean deviation (MD) of the visual field between 0 to -12dB
No significant central vision loss within 5 degrees within 5th percentile
Disqualifiers
Angle closure glaucoma or narrow angle status post laser peripheral iridotomy (LPI), or any other open angle glaucoma excluding NTG
History of SLT within last 2 years
History intraocular surgery including refractive surgery, except for history of cataract surgery that has been greater than 1 year
Patients anticipating cataract surgery during the study follow-up period
Trial design
Treatments tested in this trial
- Direct Selective Laser Trabeculoplasty (DSLT)
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Ngoc Nguyen Inc.
Lead sponsor
Alcon Research
Collaborator
Source ClinicalTrials.gov